AIM WINNERS & LOSERS: CRISM rises; Intercede warns on earnings miss
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More
| Price | 13.50p on 20-03-2026 at 05:12:27 |
|---|---|
| Change | 0.00p 0% |
| Buy | 14.00p |
| Sell | 13.00p |
| Last Trade: | Unknown 50,000.00 at 13.16p |
| Day's Volume: | 0 |
| Last Close: | 13.50p |
| Open: | 0.00p |
| ISIN: | VGG042401262 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 7.00p - 29.00p |
| Market Capitalisation: | £6.98m |
| VWAP: | 0.00p |
| Shares in Issue: | 51.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Crism Thera (CRTX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 50,000 | 13.16p | Ordinary |
15:01:37 - 19-Mar-26 |
| Buy* | 36,493 | 13.69p | Ordinary |
15:00:15 - 19-Mar-26 |
| Buy* | 114 | 14.00p | SI Trade |
12:49:45 - 19-Mar-26 |
| Buy* | 229 | 14.00p | SI Trade |
12:49:45 - 19-Mar-26 |
| Buy* | 80 | 14.00p | SI Trade |
12:49:45 - 19-Mar-26 |
| Sell* | 884 | 13.00p | SI Trade |
12:49:45 - 19-Mar-26 |
| Buy* | 31 | 14.00p | SI Trade |
12:49:45 - 19-Mar-26 |
| Buy* | 172 | 14.00p | SI Trade |
12:49:45 - 19-Mar-26 |
| Buy* | 64 | 14.00p | SI Trade |
12:49:45 - 19-Mar-26 |
| Buy* | 714 | 14.00p | SI Trade |
12:49:45 - 19-Mar-26 |
Crism Thera (CRTX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Mar 2026 7:00 am | RNS | Awarding of Orphan Drug Designation by the FDA |
| 17th Mar 2026 7:00 am | RNS | Awarding of Orphan Drug Designation by the FDA |
| 20th Jan 2026 7:00 am | RNS | Japanese Patent Grant |
| 9th Jan 2026 7:00 am | RNS | Results of Shareholder Analysis |
| 15th Dec 2025 2:29 pm | RNS | Result of Retail Offer |
| 10th Dec 2025 7:25 am | RNS | Retail Offer |
| 10th Dec 2025 7:00 am | RNS | Placing of £1,000,000 |
| 27th Nov 2025 7:00 am | RNS | Holding(s) in Company |
| 30th Oct 2025 7:00 am | RNS | US Orphan Drug Designation Application |
| 14th Oct 2025 7:00 am | RNS | Positive Preclinical Data in Prostate Cancer |